Research Agenda Working Group

Chair: Fareed Mirza, Head of Research, Novartis Foundation

The Research Agenda Working Group will develop an aligned research agenda for current and potential future innovations in diagnostics, strategies, and interventions to contribute to zero leprosy. The prioritized research agenda is intended to support advocacy for investment.

Its sub-groups will develop research priorities in seven key areas:

Diagnostic tests (PCR, T-cell and other immunological-based tests)Facilitator:Dr. Milton Moraes, Assistant General Coordinator of Postgraduate Programs and Manager of the technological platforms for genotyping and gene expression of the Technological Development Program for Health Inputs (PDTIS), Oswaldo Cruz Institute, FIOCRUZ

Call for ParticipantsThe sub-groups will assess current research that is currently in progress, prioritize the new research needed to reach the goal of zero leprosy, and explore promising cross-cutting opportunities, such as digital technologies. Scientists and researchers in leprosy or other NTD areas are encouraged to apply. Persons affected by leprosy and country programme managers are also welcome to apply and bring their perspective to the groups.

Criteria:

Expertise in one of the sub-group topic areas.

Availability to participate in conference calls during the September-October timeframe.

Ability to review drafts and provide comments within a short timeframe.